Literature DB >> 20199468

The use of oral ketamine for analgesia with dressing change in an infant with epidermolysis bullosa: report of a case.

John M Saroyan1, Mary E Tresgallo, Christiana Farkouh, Kimberly D Morel, William S Schechter.   

Abstract

Epidermolysis bullosa (EB) describes a spectrum of disease from occasional bullae and callus formation to a debilitating life-threatening condition. In this study, we report the use of intravenous ketamine given orally to an infant with a phenotypically severe form of EB simplex, Dowling-Meara subtype, to achieve analgesia during painful dressing changes.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20199468     DOI： 10.1111/j.1525-1470.2009.01036.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  4 in total

1.  A consensus approach to wound care in epidermolysis bullosa.

Authors:  Elena Pope; Irene Lara-Corrales; Jemima Mellerio; Anna Martinez; Gregory Schultz; Robert Burrell; Laurie Goodman; Patricia Coutts; John Wagner; Upton Allen; Gary Sibbald
Journal:  J Am Acad Dermatol       Date:  2012-03-02       Impact factor: 11.527

Review 2.  Pharmacological treatment of chronic non-cancer pain in pediatric patients.

Authors:  Eapen Mathew; Eugene Kim; Kenneth R Goldschneider
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

3.  Pain care for patients with epidermolysis bullosa: best care practice guidelines.

Authors:  Kenneth R Goldschneider; Julie Good; Emily Harrop; Christina Liossi; Anne Lynch-Jordan; Anna E Martinez; Lynne G Maxwell; Danette Stanko-Lopp
Journal:  BMC Med       Date:  2014-10-09       Impact factor: 8.775

Review 4.  Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.

Authors:  May El Hachem; Giovanna Zambruno; Eva Bourdon-Lanoy; Annalisa Ciasulli; Christiane Buisson; Smail Hadj-Rabia; Andrea Diociaiuti; Carolina F Gouveia; Angela Hernández-Martín; Raul de Lucas Laguna; Mateja Dolenc-Voljč; Gianluca Tadini; Guglielmo Salvatori; Cristiana De Ranieri; Stephanie Leclerc-Mercier; Christine Bodemer
Journal:  Orphanet J Rare Dis       Date:  2014-05-20       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.